Print
Email
Print Edition StoriesThursday, December 18, 2008
Entra Pharmaceuticals gathers first round funds
By Mass High Tech staff
Waltham-based drug delivery startup Entra Pharmaceuticals Inc. has raised $4.23 million in a first tranche of a Series A round, which could be expanded to $12.5 million by November 30, 2009, according to PE Hub, which cited regulatory filings. Backers reportedly include Flybridge Capital Partners and North Bridge Venture Partners.
The low-profile company is housed at North Bridge’s offices in Waltham. For an event at the Deshpande Center earlier this year, North Bridge background materials listed Entra as one of the MIT spinouts that it has funded. Other reports have listed Rick Gyory, formerly of Transform Pharmaceuticals, as president and as vice president for product design and development.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
